17:28 EST Revolution Medicines files automatic mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on RVMD:
- Revolution Medicines price target raised to $42 from $41 at Wedbush
- Revolution Medicines sees FY24 GAAP net loss $480M-$520M
- Revolution Medicines reports Q4 EPS ($1.14) , consensus (88c)
- Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress
- RVMD Upcoming Earnings Report: What to Expect?